A phase-i study of repeated therapy with
โ
J. A. Ledermann; R. H. J. Begent; C. Massof; A. M. B. Kelly; T. Adam; K. D. Bags
๐
Article
๐
1991
๐
John Wiley and Sons
๐
French
โ 627 KB
The anti-mouse antibody response was examined in patients receiving repeated i.v. therapy with radiolabelled mouse monoclonal antibody (MAb) to carcinoembryonic antigen (CEA): l 3 I l anti-CEA was given approximately every 2 weeks with cyclosporin A, to suppress the anti-mouse antibody response. Two